Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Hamano

Showing results (11-20 of 12) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 12 results.
Leukemia|October 7, 2015
A20 targets caspase-8 and FADD to protect HTLV-I-infected cellsY Saitoh, A Hamano, K Mochida, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 16, 2001
SEA0400, a novel and selective inhibitor of the Na+-Ca2+ exchanger, attenuates reperfusion injury in the in vitro and in vivo cerebral ischemic modelsT Matsuda, N Arakawa, K Takuma, et al.
Pageof 2

Showing results (11-20 of 12) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 12 results.
Leukemia|October 7, 2015
A20 targets caspase-8 and FADD to protect HTLV-I-infected cellsY Saitoh, A Hamano, K Mochida, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 16, 2001
SEA0400, a novel and selective inhibitor of the Na+-Ca2+ exchanger, attenuates reperfusion injury in the in vitro and in vivo cerebral ischemic modelsT Matsuda, N Arakawa, K Takuma, et al.
Pageof 2